NuPET™ Insert for Simultaneous Preclinical PET/MRI Imaging LEARN MORE Simultaneous Preclinical PET/MRI in the widest variety of MRIs with NuPET™ LEARN MORE Rat (230g) injected with 21.4 MBq of 18F-FDG and scanned simultaneously with PET and a FISP MRI sequence using a Cubresa NuPET™ MR-compatible PET Scanner inside a 7T MRI. Courtesy of the University of Manitoba. LEARN MORE A mixture of 18F-FDG PET agent and MultiHance® MRI agent was injected IV into a flank tumor model of human A549 lung cancer. The large tumor and a small portion of the mouse body are shown in this axial image orientation. Left: Average 18F-FDG PET signal overlaid on an anatomical MR image shows relative glucose uptake. Right: Dynamic Contrast Enhancement (DCE) MRI
 was used to construct a map of relative vascular permeability. Courtesy of University of Arizona. LEARN MORE

 

Reveal Disease & Therapeutic Mechanisms with Simultaneous Molecular & Functional Imaging

Non-invasively generate 3D images of biochemical processes in live animals with Cubresa’s in-bore NuPET™ Positron Emission Tomography (PET) imaging system for your existing preclinical Magnetic Resonance Imaging (MRI) system. Add precisely registered molecular imaging to high-resolution anatomic imaging with simultaneous PET/MR imaging. Correlate time-dependent molecular mechanisms to functional response with significantly shorter acquisition times and maximized throughput.

An Easy Addition to Your Small-Animal Preclinical MRI System

Advanced solid-state, chip-based detectors optimized for small-animal subjects preserve important performance parameters such as spatial resolution and sensitivity. With the industry’s most compact footprint, Cubresa’s PET scanner integrates with existing preclinical MRI systems to deliver simultaneous PET/MR imaging without impacting standalone MRI performance.

PET and SPECT Imaging

Cubresa offers a suite of molecular imaging tools for performing small-animal in vivo research. Our PET systems and Single Photon Emission Computed Tomography (SPECT) technology have the sensitivity to track compound distribution in vivo, and can also be paired with anatomical imaging techniques like Computed Tomography (CT) to quantify tracer concentrations in organs of interest.